These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 7361617)

  • 1. "Neuraminidase-resistant" sialic acid residues of gangliosides.
    Schauer R; Veh RW; Sander M; Corfield AP; Wiegandt H
    Adv Exp Med Biol; 1980; 125():283-94. PubMed ID: 7361617
    [No Abstract]   [Full Text] [Related]  

  • 2. Enzymic degradation of gangliosides.
    Li YT; King MJ; Li SC
    Adv Exp Med Biol; 1980; 125():93-104. PubMed ID: 7361629
    [No Abstract]   [Full Text] [Related]  

  • 3. Horse erythrocyte gangliosides: preparation of the major hematoside NeuNG1-Lac-Cer.
    Maget-Dana R; Michalski JC
    Lipids; 1980 Sep; 15(9):682-5. PubMed ID: 7421423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Action of neuraminidase from Clostridium perfringens of Tay-Sachs ganglioside.
    Wenger DA; Wardell S
    Physiol Chem Phys; 1972; 4(3):224-30. PubMed ID: 4376840
    [No Abstract]   [Full Text] [Related]  

  • 5. An improved method for the measurement of total lipid-bound sialic acids after cleavage of alpha 2,8 sialic acid linkage with Vibrio cholerae sialidase in the presence of cholic acid, SDS and Ca2+.
    Maliakal MA; Ravindranath MH; Irie RF; Morton DL
    Glycoconj J; 1994 Apr; 11(2):97-104. PubMed ID: 7804012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sialic acid release by Vibrio cholerae sialidase (neuraminidase) from the outer surface of neural cells is greatly raised by halothane.
    Knight PR; Nahrwold ML; Rosenberg A
    J Neurochem; 1978 Jun; 30(6):1645-7. PubMed ID: 671010
    [No Abstract]   [Full Text] [Related]  

  • 7. Determination of sialic acids.
    Reuter G; Schauer R
    Methods Enzymol; 1994; 230():168-99. PubMed ID: 8139495
    [No Abstract]   [Full Text] [Related]  

  • 8. Hydrolysis of all gangliosides, including GM1 and GM2, on thin-layer plates by Vibrio cholerae neuraminidase.
    Portoukalian J; Bouchon B
    J Chromatogr; 1986 Aug; 380(2):386-92. PubMed ID: 3760066
    [No Abstract]   [Full Text] [Related]  

  • 9. VCN-releasable sialic acid and gangliosides in human neuroblastomas.
    Shochat SJ; Abt AB; Schengrund CL
    J Pediatr Surg; 1977 Jun; 12(3):413-8. PubMed ID: 874729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrolysis of gangliosides in micellar and liposomal dispersion by bacterial neuraminidases.
    Gatt S; Gazit B; Cestaro B; Barenholz Y
    Adv Exp Med Biol; 1980; 125():137-46. PubMed ID: 6244720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of Vibrio cholerae sialidase action on gangliosidic substrates at different supramolecular-organizational levels.
    Venerando B; Cestaro B; Fiorilli A; Ghidoni R; Preti A; Tettamanti G
    Biochem J; 1982 Jun; 203(3):735-42. PubMed ID: 7115311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in the incorporation of N-(acetyl-3 H)mannosamine into the sialic acid of the major retinal gangliosides, studied in vivo.
    Holm M; Månsson JE
    FEBS Lett; 1974 Sep; 46(1):200-2. PubMed ID: 4420170
    [No Abstract]   [Full Text] [Related]  

  • 13. Inactivation of the biological activities of the thermostable direct hemolysin of Vibrio parahaemolyticus by ganglioside Gt1.
    Takeda Y; Takeda T; Honda T; Miwatani T
    Infect Immun; 1976 Jul; 14(1):1-5. PubMed ID: 947841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuraminidase gangliosides interactions.
    Tettamanti G; Cestaro B; Venerando B; Preti A
    Adv Exp Med Biol; 1978; 101():417-37. PubMed ID: 665377
    [No Abstract]   [Full Text] [Related]  

  • 15. The ganglioside content of the milk fat-globule membrane and the mouse mammary-tumour virus isolated from the milk of infected mice. Partial characterization of a new disialoganglioside.
    Gosselin-Rey C; Gosselin L; Calberg-Bacq CM; François C; Kozma S; Osterrieth PM; Van Dessel G
    Eur J Biochem; 1980; 107(1):25-30. PubMed ID: 6249587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of Vibrio cholerae neuraminidase by a novel mechanism-based fluorescent labeling reagent.
    Hinou H; Kurogochi M; Shimizu H; Nishimura S
    Biochemistry; 2005 Sep; 44(35):11669-75. PubMed ID: 16128567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The preparation of Tay-Sachs ganglioside specifically labeled in either the N-acetylneuraminosyl or N-acetylgalactosaminyl portion of the molecule.
    Tallman JF; Kolodny EH; Brady RO
    Methods Enzymol; 1975; 35():541-8. PubMed ID: 1121293
    [No Abstract]   [Full Text] [Related]  

  • 18. Association of endogenous substrate with solubilized bovine brain sialidase.
    Schengrund CL; Repman MA
    J Neurosci Res; 1986; 15(2):175-84. PubMed ID: 3959129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis and quantitation of gangliosides as p-bromophenacyl derivatives by high-performance liquid chromatography.
    Nakabayashi H; Iwamori M; Nagai Y
    J Biochem; 1984 Oct; 96(4):977-84. PubMed ID: 6520128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of neuraminidase for improving the properties of the erythrocytic ganglioside diagnosticum].
    Dolmatova LA; Goloseev IuA; Narbugovich NI; Efremenko VI; Vladimtseva IV
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Sep; (9):35-7. PubMed ID: 4072495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.